Advertisement

Topics

ARCA biopharma Announces Genetic-Af Data And Safety Monitoring Board Recommendation To Complete Phase IIb Genetic-Af Clinical Trial Based On Efficacy And Safety Data In Phase IIb Interim Analysis

20:00 EDT 9 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: ARCA biopharma Announces Genetic-Af Data And Safety Monitoring Board Recommendation To Complete Phase IIb Genetic-Af Clinical Trial Based On Efficacy And Safety Data In Phase IIb Interim Analysis

NEXT ARTICLE

More From BioPortfolio on "ARCA biopharma Announces Genetic-Af Data And Safety Monitoring Board Recommendation To Complete Phase IIb Genetic-Af Clinical Trial Based On Efficacy And Safety Data In Phase IIb Interim Analysis"

Quick Search
Advertisement